DD01 significantly reduces liver fat by at least 30% in 76% of adults with MASH or MASLD after 12 weeks, outperforming placebo in a phase 2 trial.
Diabetes, Cardiovascular Risks, and Lipoproteins
Moving in medRxiv, Gut, JAMA, Journal of hepatology, Annals of Internal Medicine, The lancet. Gastroenterology & hepatology.
- Moved this week
- 0
Rebuilt
Moved this week
Nothing in this area has moved yet this week.
Latest in Diabetes, Cardiovascular Risks, and Lipoproteins
Newest first · last 60 days
The 2025 VA/DoD lipid management guideline recommends more intensive therapy for high-risk patients, including combination treatments and new risk assessment tools.
Pre-pregnancy parental obesity significantly increases the risk of adult offspring MASLD, with a 3.73-fold higher odds when both parents are overweight or obese.
- 3 cites
Over 50% of US adults with atherosclerotic cardiovascular disease have LDL-C levels above 2026 guideline targets, highlighting significant gaps in lipid management.
Browse JClub
Journals this month
- bioRxiv5569
- medRxiv1746
- Environ Res485
- PNAS463
- Sci Adv439
- JAMA255
- Cell Rep210
- BMJ205
- Nat Commun177
- Environ Pollution170
- Lancet149
- Science138
- NEJM119
- Applied & Environ Microbio116
- Curr Biol116
- J Exp Bot115
- mBio109
- Nature104
Moving areas, week to 3 Oct 2026
- Single-cell and spatial transcriptomics10
- Artificial Intelligence in Healthcare and Education8
- CAR-T cell therapy research7
- Neuroinflammation and Neurodegeneration Mechanisms6
- Lung Cancer Treatments and Mutations5
- Diabetes Treatment and Management4
- Pancreatic and Hepatic Oncology Research4
- Photosynthetic Processes and Mechanisms4
- Genomics and Chromatin Dynamics4
- Gut microbiota and health4